INOZYME PHARMA, INC. Current Liabilities
INOZYME PHARMA, INC. had Current Liabilities of $42.78 million as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2025-05-14
- 2025-03-31: Liabilities, Current $42.78M.
- 2024-12-31: Liabilities, Current $33.90M.
- 2024-09-30: Liabilities, Current $18.34M.
- 2024-06-30: Liabilities, Current $15.54M.
| Period end | Liabilities, Current |
|---|---|
| 2025-03-31 | $42.78M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $33.90M 10-Q · filed 2025-05-14 |
| 2024-09-30 | $18.34M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $15.54M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $12.41M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $14.69M 10-K · filed 2025-03-10 |
| 2023-09-30 | $12.28M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $12.08M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $12.58M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $14.71M 10-K · filed 2024-03-12 |
| 2022-09-30 | $13.13M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $10.57M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $12.26M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $11.63M 10-K · filed 2023-03-22 |
| 2021-09-30 | $8.94M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $6.97M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $6.83M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $9.97M 10-K · filed 2022-03-15 |
| 2020-09-30 | $9.81M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $6.73M 10-Q · filed 2020-09-03 |
| 2019-12-31 | $3.24M 10-K · filed 2021-03-25 |